The Oncology Biosimilars Market is expanding rapidly, driven by the increasing demand for affordable cancer therapies and the rising efficacy of biosimilars in cancer treatment. Biosimilars, which are biologic products closely resembling approved reference treatments, offer a cost-effective solution to expensive oncology drugs. As cancer cases grow globally, the market for oncology biosimilars...